Glomerulonephritis - 72 Studies Found
Recruiting |
: Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis :
: 2014-02-12 :
|
Active, not recruiting |
: Eculizumab in Primary MPGN : Membranoproliferative Glomerulonephritis : 2014-03-17 : Drug: Eculizumab Other Name: Soliris |
Completed |
: Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy :
: 2009-06-03 : Drug: olmesartan medoxomil olmesartan medoxomil tablets, once daily |
Not yet recruiting |
: Daratumumab in Treatment of PGNIMD and C3 GN : Membranoproliferative Glomerulonephritis : 2017-03-20 : Drug: Daratumumab Open-label Other Name: Darzalex |
Completed |
: Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis :
: 2006-06-24 : Drug: Ng-monomethyl-L-arginine (drug) |
Completed |
: A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy : Glomerulonephritis : 2010-03-24 : Drug: Adrenocorticotrophic hormone ACTH There will be two arms to the study: one arm receive 40 units an |
Completed |
: Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy : IGA Glomerulonephritis : 2015-08-18 : Device: Holter measure of ANS in IgAN patients |
Completed |
: Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy : IGA Glomerulonephritis : 2000-08-03 : Drug: enalapril |
Completed |
: Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy : IGA Glomerulonephritis : 1999-10-18 :
|
Completed |
: Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor : Glomerulonephritis : 2007-02-20 : Drug: Ramipril 2.5mg and increase to 5mg if patient do not develop symptomatic hypotension |